Reports & Presentations
Subsidiary Financials 2017 -18
- Glenmark Life Sciences Limited
- Egypt Audit Report signed
- Glenmark Arzenimittel GmbH
- Glenmark Domnicana SRL
- Glenmark Farmaceutica Ltda
- Glenmark Generics SA
- Glenmark Holding S.A.
- Glenmark Phamaceuticals B.V.
- Glenmark Pharmaceutical (Australia) Pty. Ltd.
- Glenmark Pharmaceuticals (Kenya) Ltd.
- Glenmark Pharmaceuticals (M) SDN.BHD.
- Glenmark Pharmaceuticals (Nigeria ) Ltd
- Glenmark Pharmaceuticals (Thailand) Company Ltd
- Glenmark Pharmaceuticals Canada Inc.
- Glenmark Pharmaceuticals Columbia S.A.S.
- Glenmark Pharmaceuticals Distribution s.r.o.
- Glenmark Pharmaceuticals Ecuador S.A.
- Glenmark Pharmaceuticals Europe Limited
- Glenmark Pharmaceuticals Europe R&D Limited
- Glenmark Pharmaceuticals FZE
- Glenmark Pharmaceuticals INC.
- Glenmark Pharmaceuticals Mexico, SA DE CV
- Glenmark Pharmaceuticals Nordic AB
- Glenmark Pharmaceuticals Peru SAC
- Glenmark Pharmaceuticals S. A.
- Glenmark Pharmaceuticals S.R.L,Romania
- Glenmark Pharmaceuticals s.r.o
- Glenmark Pharmaceuticals SK s.r.o
- Glenmark Pharmaceuticals South Africa Proprietary Limited
- Glenmark Pharmaceuticals Sp. z o.o.
- Glenmark Philippines, Inc.
- Glenmark south africa proprirtary limited
- Glenmark Therap. AG
- Glenmark Ukraine LLC
- Glenmark Uruguay SA
- Glenmark Venezeula C.A.
- Viso Farmaceutica S.L.
